0001671858-20-000002.txt : 20201006 0001671858-20-000002.hdr.sgml : 20201006 20201006145842 ACCESSION NUMBER: 0001671858-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201006 DATE AS OF CHANGE: 20201006 EFFECTIVENESS DATE: 20201006 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Silverback Therapeutics, Inc. CENTRAL INDEX KEY: 0001671858 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811489190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-377225 FILM NUMBER: 201226472 BUSINESS ADDRESS: STREET 1: 500 FAIRVIEW AVENUE NORTH, SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-456-2900 MAIL ADDRESS: STREET 1: 500 FAIRVIEW AVENUE NORTH, SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98109 D 1 primary_doc.xml X0708 D LIVE 0001671858 Silverback Therapeutics, Inc. 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA WASHINGTON 98109 206-456-2900 DELAWARE None None Corporation true 2016 Laura Shawver 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA WASHINGTON 98109 Executive Officer Director Vickie L. Capps 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA WASHINGTON 98109 Director Robert Hershberg 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA WASHINGTON 98109 Director Saqib Islam 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA WASHINGTON 98109 Director Scott Platshon 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA WASHINGTON 98109 Director Jonathan Root 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA WASHINGTON 98109 Director Thilo Schroeder 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA WASHINGTON 98109 Director Peter A. Thompson 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA WASHINGTON 98109 Director Biotechnology Decline to Disclose 06b false 2020-09-22 false true false 0 84999995 84999995 0 false 31 0 0 0 true false Silverback Therapeutics, Inc. Jill Fishbein Jill Fishbein Secretary 2020-10-06